UBS Group’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
69,844
-17,742
| -20% | -$83.7K | ﹤0.01% | 5161 |
|
|
2025
Q1 | $402K | Sell |
87,586
-142,351
| -62% | -$653K | ﹤0.01% | 4828 |
|
|
2024
Q4 | $1.1M | Buy |
229,937
+143,056
| +165% | +$685K | ﹤0.01% | 4146 |
|
|
2024
Q3 | $407K | Buy |
86,881
+8,471
| +11% | +$39.7K | ﹤0.01% | 4233 |
|
|
2024
Q2 | $443K | Buy |
78,410
+12,012
| +18% | +$67.9K | ﹤0.01% | 4007 |
|
|
2024
Q1 | $273K | Sell |
66,398
-9,213
| -12% | -$37.9K | ﹤0.01% | 4511 |
|
|
2023
Q4 | $319K | Sell |
75,611
-16,575
| -18% | -$69.9K | ﹤0.01% | 4296 |
|
|
2023
Q3 | $398K | Sell |
92,186
-39,519
| -30% | -$171K | ﹤0.01% | 3771 |
|
|
2023
Q2 | $868K | Sell |
131,705
-2,206
| -2% | -$14.5K | ﹤0.01% | 3416 |
|
|
2023
Q1 | $909K | Sell |
133,911
-4,987
| -4% | -$33.9K | ﹤0.01% | 3267 |
|
|
2022
Q4 | $1.03M | Buy |
138,898
+91,895
| +196% | +$679K | ﹤0.01% | 3113 |
|
|
2022
Q3 | $464K | Sell |
47,003
-10,740
| -19% | -$106K | ﹤0.01% | 3431 |
|
|
2022
Q2 | $630K | Sell |
57,743
-74,743
| -56% | -$815K | ﹤0.01% | 3187 |
|
|
2022
Q1 | $1.5M | Buy |
132,486
+77,578
| +141% | +$877K | ﹤0.01% | 2899 |
|
|
2021
Q4 | $861K | Buy |
54,908
+5,284
| +11% | +$82.9K | ﹤0.01% | 3557 |
|
|
2021
Q3 | $850K | Buy |
49,624
+46,923
| +1,737% | +$804K | ﹤0.01% | 3373 |
|
|
2021
Q2 | $58K | Sell |
2,701
-71,063
| -96% | -$1.53M | ﹤0.01% | 5251 |
|
|
2021
Q1 | $1.11M | Buy |
73,764
+9,274
| +14% | +$139K | ﹤0.01% | 3271 |
|
|
2020
Q4 | $847K | Buy |
64,490
+54,379
| +538% | +$714K | ﹤0.01% | 3273 |
|
|
2020
Q3 | $98K | Sell |
10,111
-15,748
| -61% | -$153K | ﹤0.01% | 4366 |
|
|
2020
Q2 | $296K | Buy |
25,859
+23,304
| +912% | +$267K | ﹤0.01% | 3746 |
|
|
2020
Q1 | $26K | Sell |
2,555
-72,624
| -97% | -$739K | ﹤0.01% | 5433 |
|
|
2019
Q4 | $1.23M | Sell |
75,179
-4,209
| -5% | -$69.1K | ﹤0.01% | 3156 |
|
|
2019
Q3 | $1.05M | Buy |
79,388
+73,046
| +1,152% | +$970K | ﹤0.01% | 3158 |
|
|
2019
Q2 | $90K | Sell |
6,342
-600
| -9% | -$8.52K | ﹤0.01% | 4604 |
|
|
2019
Q1 | $127K | Sell |
6,942
-163,504
| -96% | -$2.99M | ﹤0.01% | 4138 |
|
|
2018
Q4 | $4.45M | Buy |
170,446
+144,907
| +567% | +$3.79M | ﹤0.01% | 1786 |
|
|
2018
Q3 | $586K | Buy |
25,539
+15,460
| +153% | +$355K | ﹤0.01% | 3550 |
|
|
2018
Q2 | $192K | Sell |
10,079
-74,660
| -88% | -$1.42M | ﹤0.01% | 4123 |
|
|
2018
Q1 | $1.43M | Buy |
84,739
+22,382
| +36% | +$377K | ﹤0.01% | 2769 |
|
|
2017
Q4 | $947K | Sell |
62,357
-66,748
| -52% | -$1.01M | ﹤0.01% | 3052 |
|
|
2017
Q3 | $2.31M | Buy |
129,105
+114,667
| +794% | +$2.05M | ﹤0.01% | 2384 |
|
|
2017
Q2 | $235K | Buy |
14,438
+2,618
| +22% | +$42.6K | ﹤0.01% | 3815 |
|
|
2017
Q1 | $165K | Sell |
11,820
-29,878
| -72% | -$417K | ﹤0.01% | 3917 |
|
|
2016
Q4 | $666K | Buy |
41,698
+22,586
| +118% | +$361K | ﹤0.01% | 3111 |
|
|
2016
Q3 | $319K | Sell |
19,112
-16,237
| -46% | -$271K | ﹤0.01% | 3422 |
|
|
2016
Q2 | $396K | Buy |
35,349
+10,563
| +43% | +$118K | ﹤0.01% | 3310 |
|
|
2016
Q1 | $207K | Sell |
24,786
-113,560
| -82% | -$948K | ﹤0.01% | 3759 |
|
|
2015
Q4 | $1.29M | Buy |
138,346
+109,346
| +377% | +$1.02M | ﹤0.01% | 2513 |
|
|
2015
Q3 | $327K | Buy |
29,000
+222
| +0.8% | +$2.5K | ﹤0.01% | 3382 |
|
|
2015
Q2 | $366K | Buy |
28,778
+25,278
| +722% | +$321K | ﹤0.01% | 3466 |
|
|
2015
Q1 | $32K | Buy |
3,500
+1,500
| +75% | +$13.7K | ﹤0.01% | 5003 |
|
|
2014
Q4 | $29K | Buy |
+2,000
| New | +$29K | ﹤0.01% | 5187 |
|